APNAR PHARMA LP FDA Approval ANDA 075049

ANDA 075049

APNAR PHARMA LP

FDA Drug Application

Application #075049

Documents

Letter2004-06-04
Letter2004-06-04
Letter2003-04-09
Letter2003-04-09
Letter2003-04-09
Letter2003-04-09
Letter2003-04-09
Label2004-06-04
Review2003-08-04
Other Important Information from FDA2005-08-01
Letter2003-04-09
Letter2003-04-09
Letter2003-04-09

Application Sponsors

ANDA 075049APNAR PHARMA LP

Marketing Status

Prescription001
Prescription002
Prescription003

Application Products

001CAPSULE;ORALEQ 10MG BASE0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE
002CAPSULE;ORALEQ 20MG BASE0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE
003CAPSULE;ORALEQ 40MG BASE0FLUOXETINE HYDROCHLORIDEFLUOXETINE HYDROCHLORIDE

FDA Submissions

ORIG1AP2001-08-02
MANUF (CMC); Manufacturing (CMC)SUPPL2AP2002-01-29
LABELING; LabelingSUPPL3AP2002-01-29
MANUF (CMC); Manufacturing (CMC)SUPPL4AP2002-01-29
MANUF (CMC); Manufacturing (CMC)SUPPL5AP2002-01-29
MANUF (CMC); Manufacturing (CMC)SUPPL7AP2002-01-29
LABELING; LabelingSUPPL8AP2002-01-29
MANUF (CMC); Manufacturing (CMC)SUPPL9AP2002-01-29
LABELING; LabelingSUPPL10AP2002-01-29
LABELING; LabelingSUPPL11AP2003-11-19
LABELING; LabelingSUPPL12AP2004-09-13
LABELING; LabelingSUPPL13AP2004-09-13
LABELING; LabelingSUPPL14AP2005-06-09
LABELING; LabelingSUPPL17AP2005-06-09
LABELING; LabelingSUPPL19AP2006-01-31
LABELING; LabelingSUPPL20AP2006-11-06
LABELING; LabelingSUPPL21AP2007-11-07
LABELING; LabelingSUPPL23AP2007-11-07
LABELING; LabelingSUPPL27AP2008-10-21
LABELING; LabelingSUPPL30AP2009-08-21
LABELING; LabelingSUPPL32AP2010-08-09
LABELING; LabelingSUPPL35AP2020-09-28STANDARD
LABELING; LabelingSUPPL36AP2020-09-28STANDARD
LABELING; LabelingSUPPL39AP2020-09-28STANDARD
LABELING; LabelingSUPPL40AP2020-09-28STANDARD
LABELING; LabelingSUPPL42AP2020-09-28STANDARD

Submissions Property Types

SUPPL2Null0
SUPPL4Null0
SUPPL5Null0
SUPPL7Null0
SUPPL9Null0
SUPPL30Null7
SUPPL35Null15
SUPPL36Null7
SUPPL39Null15
SUPPL40Null15
SUPPL42Null15

TE Codes

001PrescriptionAB1
002PrescriptionAB1
003PrescriptionAB

CDER Filings

APNAR PHARMA LP
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 75049
            [companyName] => APNAR PHARMA LP
            [docInserts] => ["",""]
            [products] => [{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 10MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 20MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"FLUOXETINE HYDROCHLORIDE","activeIngredients":"FLUOXETINE HYDROCHLORIDE","strength":"EQ 40MG BASE","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"08\/02\/2001","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/anda\\\/2001\\\/75049_FLUOXETINE_Prntlbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"FLUOXETINE HYDROCHLORIDE","submission":"FLUOXETINE HYDROCHLORIDE","actionType":"EQ 10MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"FLUOXETINE HYDROCHLORIDE","submission":"FLUOXETINE HYDROCHLORIDE","actionType":"EQ 20MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"FLUOXETINE HYDROCHLORIDE","submission":"FLUOXETINE HYDROCHLORIDE","actionType":"EQ 40MG BASE","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2001-08-02
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.